Coagulation disorders in cancer

Hematology/Oncology Clinics of North America

Volumn 10, Issue 2, 1996, Pages 457-484

  Goad, K E ^a   Gralnick, H R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ANTITHROMBIN III; ASPARAGINASE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DANAPAROID; DAUNORUBICIN; FLUOROURACIL; HEPARIN; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; METHOTREXATE; MITOMYCIN C; PROTEIN C; PROTEIN S; RETINOIC ACID; RHESUS D ANTIBODY; TAMOXIFEN; TIOGUANINE; TRANEXAMIC ACID; VINBLASTINE; VITAMIN K GROUP; WARFARIN;

ACUTE MYELOBLASTIC LEUKEMIA; AMYLOIDOSIS; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; DISSEMINATED INTRAVASCULAR CLOTTING; HEMOLYTIC UREMIC SYNDROME; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVENOUS DRUG ADMINISTRATION; MALIGNANT NEOPLASTIC DISEASE; PARAPROTEINEMIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW; THROMBOCYTE ANOMALY; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHLEBITIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VITAMIN K DEFICIENCY; VON WILLEBRAND DISEASE;

EID: 0029918207     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70347-6     Document Type: Article

References (308)

1. T.C. Abshire S.H. Gold L.F. Odom The coagulopathy of childhood leukemia Thrombin activation or primary fibrinolysis? Cancer 66 1990 716 721
2. B. Adelman M. Sobel Y. Fujimura Heparin-associated thrombocytopenia: on the mechanism of platelet aggregation J Lab Clin Med 113 1989 204 210
3. D.J. Ahr S.J. Scialla D.J. Kimbali Acquired platelet dysfunction following mithramycin therapy Cancer 41 1978 448 454
4. M.G. Alessio A. Falanga R. Consonni Cancer procoagulant in acute lymphoblastic leukemia Eur J Haematol 45 1990 78 81
5. D.P. Alexander M.E. Russo D.E. Fohrman G. Rothstein Nafcillin-induced platelet dysfunction and bleeding Antimicrob Agents Chemother 23 1983 59 62
6. J. Amiral F. Bridey M. Dreyfus Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia [letter] [see comments] Thromb Haemost 68 1992 95 96
7. K. Andon T. Kubota M. Takada Tissue factor activity in leukemia cells. Special reference to disseminated intravascular coagulation Cancer 59 1987 748 754
8. K. Andrassy E. Ritz B. Hasper Penicillin-induced coagulation disorder Lancet 2 1976 1039 1041
9. J. Ansell N.J. Slepchuk R. Kumar Heparin induced thrombocytopenia: A prospective study Thromb Haemost 43 1980 61 65
10. C.K. Arthur J.P. Isbister E.M. Aspery The heparin induced syndrome (H.I.T.T.S.): A review Pathology 17 1985 82 86
11. M.J. Auger M.J. Mackie Haemostasis in malignant disease J R Coll Physicians Lond 22 1988 74 79
12. G. Avvisati G.J. Ten M.R. Buller F. Mandelli Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia Lancet 2 1989 122 124
13. R.J. Bailey J.A. Ursick K.L. Heim Heparin-associated thrombocytopenia: A prospective comparison of bovine lung heparin, manufactured by a new process, and porcine intestinal heparin Drug Intelligence and Clinical Pharmacy 20 1986 374 378
14. S. Bajaj S. Rapaport D.E.A. Fierer A mechanism for the hypoprothrombinemia of the acquired anticoagulant syndrome Blood 61 1983 684
15. E. Bastida L. Almirall A. Ordinas Tumor-cell-induced platelet aggregation is a glycoprotein-dependent and lipoxygenase-associated process Int J Cancer 39 1987 760 763
16. E. Bastida A. Ordinas G. Escolar G.A. Jamieson Tissue factor in shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and Blood 64 1984 177 184
17. E. Bastida A. Ordinas S.L. Giardina G.A. Jamieson Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition studies with apyrase, hirudin, and phospholipase Cancer Res 42 1982 4348 4352
18. K.A. Bauer R.D. Rosenberg Thrombin generation in acute promyelocytic leukemia Blood 64 1984 791 796
19. W.R. Bell H.G. Braine P.M. Ness T.S. Kickler Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients [see comments] N Engl J Med 325 1991 398 403
20. W.R. Bell R.M. Royall Heparin-associated thrombocytopenia: A comparison of three heparin preparations N Engl J Med 303 1980 902 907
21. W.R. Bell N.F. Starksen S. Tong J.K. Porterfield Trousseau's syndrome. Devastating coagulopathy in the absence of heparin Am J Med 79 1985 423 430
22. F.K. Beller G.W. Douglas Thrombocytopenia indicating gram-negative infection and endotoxemia Obstet Gynecol 41 1973 521 524
23. A.C. Benhamou Y. Gruel J. Barsotti The white clot syndrome or heparin associated thrombocytopenia and thrombosis (WCS or HATT) (26 cases) International Angiology 4 1985 303 310
24. B. Bennett N.A. Booth A. Croll A.A. Dawson The bleeding disorder in acute promyelocytic leukaemia: Fibrinolysis due to u-PA rather than defibrination Br J Haematol 71 1989 511 517
25. J.J. Bergin W.H. Crosby E.J. Jahnke Massive bleeding with fibrinolysis: Management with heparin and epsilon aminocaproic acid Mil Med 131 1966 340 344
26. M.M. Bern J.J. Lokich S.R. Wallach Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial Ann Intern Med 112 1990 423 428
27. J. Bernard M. Weil M. Boiron Acute promyelocytic leukemia: Results of treatment by daunorubicin Blood 41 1973 489 496
28. B. Bernhardt M. Valletta J. Brook I. Lejnieks Amyloidosis with factor X deficiency Am J Med Sci 264 1972 411 414
29. R.L. Bick Alterations of hemostasis associated with malignancy: Etiology, pathophysiology, diagnosis and management Semin Thromb Hemost 5 1978 1 26
30. N.A. Booth B. Bennett Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis Br J Haematol 56 1984 545 556
31. E.G. Bovill W.B. Ershler E.A. Golden A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor Am J Clin Pathol 85 1986 115 123
32. J.I. Brody M.E. Haidar R.E. Rossman A hemorrhagic syndrome in macroglobulinemia secondary to immunoadsorption of factor VIII. Recovery after splenectomy N Engl J Med 300 1979 408 410
33. L.F. Brown M.J. Bradshaw E.A. Natelson Defective platelet function following the administration of penicillin compounds Blood 47 1976 949 956
34. L.F. Brown E.A. Natelson M.W. Bradshaw Study of the effects of ticarcillin on blood coagulation and platelet function Antimicrob Agents Chemother 7 1975 652 657
35. L.F. Brown E.A. Natelson W. Bradshaw The hemostatic defect produced by carbenicillin N Engl J Med 291 1974 265 270
36. U. Budde J.A. Dent S.D. Berkowitz Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome Blood 68 1986 1213 1217
37. S.F. Burroughs G.J. Johnson Beta-lactam platelet dysfunction: Evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin Blood 75 1990 1473 1480
38. J.J. Byrnes J.L. Moake Thrombotic thrombocytopenic purpura and the syndrome: Evolving concepts of pathogenesis and therapy Clin Haematol 15 1986 413 42
39. N.S. Callander N. Varki Rao Immunohistochemical identification of tissue factor in solid tumors Cancer 70 1992 1194 1201
40. L. Canobbio T. Fassio A. Ardizzoni Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patients Cancer 58 1986 1032 1036
41. R.W. Carey A. McGinnis B.M. Jacobson A. Carvalho Idiopathic thrombocytopenic purpura complicating chronic lymphocytic leukemia Arch Intern Med 136 1976 62 66
42. S. Carlsson Fibrinogen degradation products in serum from patients with cancer Acta Chir Scand 139 1973 499 502
43. P.A. Castaldi R. Penny A macroglobulin with inhibitory activity against coagulation factor VIII Blood 35 1970 370 376
44. P.G. Cavanaugh B.F. Sloane A.S. Bajkowski Purification and of platelet aggregating activity from tumor cells: Copurification with procoagulant activity Thromb Res 37 1985 309 326
45. P.G. Cavanaugh B.F. Sloane K.V. Honn Role of the coagulation system in tumorcell-induced platelet aggregation and metastasis Haemostasis 18 1988 37 46
46. J.P. Cazenave M.A. Guccione M.A. Packham J.F. Mustard Effects of cephalothin and penicillin G on platelet function in vitro Br J Haematol 35 1977 135 152
47. C.P. Chang J. Zhao T. Wiedmer J. Sims Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine J Biol Chem 268 1993 7171 7178
48. J.C. Chang K.K. Kane Pathologic hyperfibrinolysis associated with amyloidosis: Clinical response to epsilon amino caproic acid Am J Clin Pathol 81 1984 382 387
49. G.S. Chapman C.B. George D.L. Danley Heparin-like anticoagulant associated with plasma cell myeloma Am J Clin Pathol 83 1985 764 766
50. Chong BH, Fawaz I, Chesterman CN, Berndt MC: Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets.
51. B.H. Chong F. Ismail J. Cade Heparin-induced thrombocytopenia: Studies with a new low molecular weight heparinoid, Org 10172 Blood 73 1989 1592 1596
52. D.B. Cines P. Kaywin M. Bina Heparin-associated thrombocytopenia N Engl J Med 303 1980 788 795
53. R.J. Cipolle K.A. Rodvold R. Seifert Heparin-associated thrombocytopenia: A prospective evaluation of 211 patients Ther Drug Monit 5 1983 205 211
54. G.P. Clagett J.S. Reisch Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis Ann Surg 208 1988 227 240
55. M. Clauss M. Gerlach H. Gerlach Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration J Exp Med 172 1990 1535 1545
56. M. Clauss J.C. Murray M. Vianna A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis J Biol Chem 265 1990 7078 7083
57. I. Cohen J. Amir S.Y. Ben Plasma cell myeloma associated with an unusual myeloma protein causing impairment of fibrin aggregation and platelet function in a patient with multiple malignancy Am J Med 48 1970 766 776
58. J.R. Cohen Idiopathic thrombocytopenic purpura in Hodgkin's disease: A rare occurence of no prognostic significance Cancer 41 1978 743 746
59. M. Coleman E.M. Vigliano M.E. Weksler R.L. Nachman Inhibition of fibrin monomer polymerization by lambda myeloma globulins Blood 39 1972 210 223
60. A.J. Collins C.D. Bloomfield B.A. Peterson Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction Arch Intern Med 138 1978 1677 1680
61. R.W. Colman J. Hirsh V.J. Marder E.W. Salzman Hemostasis and Thrombosis 1994 JB Lippincott Philadelphia
62. D.L. Cooper A.B. Sandler L.D. Wilson T.P. Duffy Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acid Cancer 70 1992 656 658
63. M.J. Coppes S.W. Zandvoort C.R. Sparling Acquired von Willebrand disease in Wilms' tumor patients J Clin Oncol 10 1992 422 427
64. C. Cordonnier J.P. Vernant B. Brun Acute promyelocytic leukemia in 57 previously untreated patients Cancer 55 1985 18 25
65. J.J. Corrigan W.L. Ray N. May Changes in the blood coagulation system associated with septicemia N Engl J Med 279 1968 851 856
66. J.K. Cottingham J.B. Wheelock Heparin-associated thrombocytopenia: A complication of low-dose heparin prophylaxis Mil Med 154 1989 242 244
67. F. Cozzolino M. Torcia A. Miliani Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia Am J Med 84 1988 240 250
68. M. Cronlund J. Hardin J. Burton A in plasma of normal subjects and patients with disseminated coagulation and systemic lupus erythematosus J Clin Invest 58 1976 142 151
69. I. Cunningham T.S. Gee L.M. Reich Acute promyelocytic leukemia: Treatment results during a decade at Memorial Hospital Blood 73 1989 1116 1122
70. C.A. D'Cruz R.S. Wimmer H.T. Harcke disease of the liver in children following chemotherapy for acute myelocytic leukemia Cancer 52 1983 1803 1807
71. P.A. Daly C.A. Schiffer P.H. Wiernik Acute promyelocytic management of 15 patients Am J Hematol 8 1980 347 359
72. K.S. Dasmahapatra N.K. Cheung C. Spillert E. Lazaro An assessment of monocyte procoagulant activity in patients with solid tumors J Surg Res 43 1987 158 163
73. F.R. Davey G.B. Gordon L.I. Boral A.J. Gottlieb Gamma globulin inhibition of fibrin clot formation Ann Clin Lab Sci 6 1976 72 77
74. R.B. Davis A. Theologides B.J. Kennedy Comparative studies of blood coagulation and platelet aggregation in patients with cancer and nonmalignant diseases Ann Intern Med 71 1969 67 80
75. L.M. Deppisch A.O. Fayemi Non-bacterial thrombotic endocarditis: Clinicopathologic correlations Am Heart J 92 1976 723 729
76. G. DiMinno F. Coraggio A.M. Cerbone A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder J Clin Invest 77 1986 157 164
77. D.C. Doll Q.S. Ringenberg J.W. Yarbro Vascular toxicity associated with agents J Clin Oncol 4 1986 1405 1417
78. B. Drewinko P. Cobb V. Guinee Untreated prostatic carcinoma is not associated with frequent disorders Urology 30 1987 11 17
79. H.F. Dvorak L.F. Brown M. Detmar A.M. Dvorak Vascular permeability factor/vascular endothelial growth factor, microvascular and angiogenesis Am J Pathol 146 1995 1029 1039
80. R.L. Edwards D.L. Morgan F.R. Rickles Animal tumor procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Committee, International Society of Thrombosis and Haemostasis Thromb Haemost 63 1990 133 138
81. R.L. Edwards F.R. Rickles M. Cronlund Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation J Lab Clin Med 98 1981 917 928
82. R.L. Edwards F.R. Rickles T.E. Moritz Abnormalities of blood coagulation tests in patients with cancer Am J Clin Pathol 88 1987 596 602
83. F.S. Ey S.H. Goodnight Bleeding disorders in cancer Semin Oncol 17 1990 187 197
84. A. Falanga M.G. Alessio M.B. Donati T. Barbui A new procoagulant in acute leukemia Blood 71 1988 870 875
85. A. Falanga S.G. Gordon Isolation and characterization of cancer procoagulant: A cysteine proteinase from malignant tissue Biochemistry 24 1985 5558 5567
86. R.J. Fass E.A. Copelan J.T. Brandt Platelet-mediated bleeding caused by broadspectrum penicillins J Infect Dis 155 1987 1242 1248
87. S.E. Feffer L.S. Carmosino R.L. Fox Acquired protein C deficiency in patients with breast cancer receiving cyclophospamaide, methotrexate, and 5-fluorouracil Cancer 63 1989 1303 1307
88. E. Fibach A. Treves A. Korenberg E.A. Rachmilewitz In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotoxic drugs Am J Hematol 20 1985 257 265
89. K. Fink M.H. Al Idiopathic thrombocytopenic purpura in lymphoma Cancer 37 1976 1999 2004
90. B. Fisher J. Costantino C. Redmond A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have tumors N Engl J Med 320 1989 479 484
91. G. Follea I. Hamandjian M.C. Trzeciak Pentosan polysulphate associated thrombocytopenia Thromb Res 42 1986 413 418
92. J.L. Francis Haemostasis and cancer Med Lab Sci 46 1989 331 346
93. J.L. Francis B.K. El O.S. Roath I. Taylor Factor X-activating activity in normal and malignant colorectal tissue Thromb Res 52 1988 207 217
94. B. Furie E. Greene B.C. Furie Syndrome of acquired factor X deficiency and systemic amyloidosis in vivo studies of the metabolic fate of factor X N Engl J Med 297 1977 81 85
95. B. Furie L. Voo K.P. McAdam B.C. Furie Mechanism of factor X deficiency in systemic amyloidosis N Engl J Med 304 1981 827 830
96. P.A. Galbraith N. Sharma W.L. Parker J.M. Kilgour Acquired factor X deficiency. Altered plasma antithrombin activity and association with amyloidosis JAMA 230 1974 1658 1660
97. P.C. Galle H.B. Muss K.M. McGrath Thrombocytopenia in two patients treated with low-dose heparin Obstet Gynecol 52 suppl 1 1978 9S 11S
98. D.J. Ganick W.J. Robertson C. Viseskul M.S. Lubinsky Dural sinus thrombosis in leukemia Med Pediatr Oncol 122 1979 235 242
99. R.A. Gill G.R. Onstad J.M. Cardamone Hepatic veno-occlusive disease caused by 6-thioguanine Ann Intern Med 96 1982 58 60
100. H.I. Glueck M.R. MacKenzie C.J. Glueck Crystalline IgG protein in multiple myeloma: Identification effects on coagulation and on lipoprotein metabolism J Lab Clin Med 79 1972 731 744
101. J. Gmur J. Burger U. Schanz Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia [see comments] Lancet 338 1991 1223 1226
102. M.A. Goldberg D. Ginsburg R.J. Mayer Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 69 1987 187 191
103. S.J. Goodnight Bleeding and intravascular clotting in malignancy: A review Ann N Y Acad Sci 230 1974 271 288
104. L.T. Goodnough H. Saito A. Manni Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients Cancer 54 1984 1264 1268
105. L.I. Gordon H.C. Kwaan E.C. Rossi Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy Semin Hematol 24 1987 194 201
106. S.G. Gordon J.J. Franks B. Lewis Cancer procoagulant A: A factor X activating procoagulant from malignant tissue Thromb Res 6 1975 127 137
107. S.G. Gordon J.J. Franks B.J. Lewis Comparison of procoagulant activities in extracts of normal and malignant human tissue J Natl Cancer Inst 62 1979 773 776
108. H.M. Gouault E. Chardon C. Sultan F. Josso The procoagulant factor of leukaemic promyelocytes: Demonstration of immunologic cross reactivity with human brain tissue factor Br J Haematol 30 1975 151 158
109. H.M. Gouault D. Payen G. Contant Thrombocytopenia related to synthetic heparin analogue therapy [letter] Thromb Haemost 54 1985 557
110. J. Goudemand B. Samor C. Caron Acquired type II von Willebrand's disease: Demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment Br J Haematol 68 1988 227 233
111. H.R. Gralnick E. Abrell Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia Br J Haematol 24 1973 89 99
112. H.R. Gralnick J. Bagley E. Abrell Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia Am J Med 52 1972 167 174
113. H.R. Gralnick M. McGinniss R. Halterman Thrombocytopenia with sodium cephalothin therapy Ann Intern Med 77 1972 401 404
114. H.R. Gralnick C. Sultan Acute promyelocytic leukaemia: Haemorrhagic manifestation and morphologic criteria Br J Haematol 29 1975 373 376
115. F. Graus L.R. Rogers J.B. Posner Cerebrovascular complications in patients with cancer Medicine (Baltimore) 64 1985 16 35
116. A. Greinacher I. Michels E.C. Mueller thrombocytopenia: The antibody is not heparin specific Thromb Haemost 67 1992 545 549
117. A. Greinacher B. Potzsch J. Amira Heparin-associatedthrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen [see comments] Thromb Haemost 71 1994 247 251
118. P.R. Greipp R.A. Kyle E.J. Bowie Factor X deficiency in primary amyloidosis: Resolution after splenectomy N Engl J Med 301 1979 1050 1051
119. G. Grignani A. Falanga L. Pacchiarini Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties Int J Cancer 42 1988 554 557
120. G. Grignani G.A. Jamieson Tissue factor-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line Invasion Metastasis 7 1987 172 182
121. P.F. Griner A. Elbadawi C.H. Packman Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases Ann Intern Med 85 1976 578 582
122. G.A. Guinn A. Ayala J. Liddicoat Clinical and therapeutic considerations in nonbacterial thrombotic endocarditis Chest 64 1973 26 28
123. D.R. Haburchak D.R. Head E.D. Everett Postoperative hemorrhage associated with carbenicillin administration. Report of two cases and review of the literature Am J Surg 134 1977 630 634
124. T. Hackett J.G. Kelton P. Powers Drug-induced platelet destruction Semin Thromb Hemost 8 1982 116 137
125. A.B. Hagedorn E.J. Bowie L.R. Elveback C.J. Owen Coagulation abnormalities in patients with inoperable lung cancer Mayo Clin Proc 49 1974 647 653
126. R.W. Hamner R. Verani E.J. Weinman renal failure. Case report and review Arch Intern Med 143 1983 803 807
127. R.I. Handin V. Martin W.C. Moloney Antibody-induced von Willebrand's disease: A newly defined inhibitor syndrome Blood 48 1976 393 405
128. Y. Hara M. Steiner M.G. Baldini Characterization of the platelet-aggregating activity of tumor cells Cancer Res 40 1980 1217 1222
129. J. Harenberg R. Zimmermann F. Schwarz W. Kubler Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid [letter] Lancet 1 1983 986 987
130. D.R. Harkness J.J. Byrnes E.C. Lian Hazard of platelet transfusion in thrombotic thrombocytopenic purpura JAMA 246 1981 1931 1933
131. R.M. Harrell R. Sibley N.J. Vogelzang Renal vascular lesions after chemotherapy with vinblastine, bleomycin, and cisplatin Am J Med 73 1982 429 433
132. K. Hassidim R. McMillan M.S. Conjalka J. Morrison Immune thrombocytopenic purpura in Hodgkin disease Am J Hematol 6 1979 149 153
133. G.S. Hedderich R.J. O'Connor E.C. Reid D.S. Mulder Caval tumor thrombus complicating renal cell carcinoma: A surgical challenge Surgery 102 1987 614 621
134. A. Hendrick V.P. Subramanian Tamoxifen and thromboembolism [letter] JAMA 243 1980 514 515
135. W.F. Hickey M.B. Garnick I.C. Henderson D.M. Dawson Primary cerebral venous thrombosis in patients with cancer-a rarely diagnosed paraneoplastic syndrome. Report of three cases and review of the literature Am J Med 73 1982 740 750
136. H. Honegger N. Anderson L.A. Hewitt J.L. Tullis Antithrombin III profiles in malignancy, relationship to primary tumors and metastatic sites Thromb Haemost 46 1981 500 503
137. M.H. Horellou J. Conrad C. Lecrubier Persistent heparin induced thrombocytopenia despite therapy with low molecular weight heparin [letter] Thromb Haemost 51 1984 134
138. M3 Horne B.R. Alkins Importance of PF4 in heparin-induced thrombocytopenia: Confirmation with gray platelets [letter] Blood 85 1995 1408 1409
139. C.F. Hoyle D.M. Swirsky L. Freedman F.G. Hayhoe Beneficial effect of heparin in the management of patients with APL Br J Haematol 68 1988 283 289
140. W.J. Hrushesky heparin-induced thrombocytopenia Arch Intern Med 138 1978 1489 1491
141. F.A. Hunt D.B. Rylatt R.A. Hart P.G. Bundesen Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems Br J Haematol 60 1985 715 722
142. K.K. Hussein M.T. Shaw S.R. Oleinick Autoimmune thrombocytopenia and peripheral neuropathy heralding Hodgkin's disease South Med J 68 1975 1414 1416
143. B.T. Hyman M.A. Westrick Multiple myeloma with polyneuropathy and coagulopathy. A case report of the polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin change (POEMS) syndrome Arch Intern Med 146 1986 993 994
144. A.M. Jackson B.D. Rose L.G. Graft Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy Ann Intern Med 101 1984 41 44
145. R.J. Jacobson S.G. Sandler C.E. Rath Systemic amyloidosis associated with haemolytic anaemia and factor X (Stuart factor) deficiency S Afr Med J 46 1972 1634 1637
146. W.D. James Trousseau's syndrome Int J Dermatol 23 1984 205 206
147. J.H. Joist J.F. Cowan T.S. Zimmerman Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder N Engl J Med 298 1978 988 991
148. S.E. Jones Autoimmune disorders and malignant lymphoma Cancer 31 1973 1092 1098
149. B. Jude J. Goudemand I. Dolle Lupus anticoagulant: A clinical and laboratory study of 100 cases Clin Lab Haematol 10 1988 41 51
150. B.R. Kaden W.F. Rosse T.W. Hauch Immune thrombocytopenia in lymphoproliferative diseases Blood 53 1979 545 551
151. H.M. Kantarjian M.J. Keating R.S. Walters Acute promyelocytic leukemia. M.D. Anderson Hospital experience Am J Med 80 1986 789 797
152. D.N. Kapsch E.H. Adelstein G.R. Rhodes D. Silver Heparin-induced thrombosis, and hemorrhage Surgery 86 1979 148 155
153. J. Kasturi A.K. Saraya Platelet functions in dysproteinaemia Acta Haematol 59 1978 104 113
154. P.A. Kaufman J.P. Gockerman C.S. Greenberg Production of a novel anticoagulant by neoplastic plasma cells: Report of a case and review of the literature Am J Med 86 1989 612 616
155. J.G. Kelton Heparin-induced Haemostasis 16 1986 173 186
156. J.G. Kelton P.B. Neame J. Gauldie J. Hirsh Elevated platelet-associated IgG in the thrombocytopenia of septicemia N Engl J Med 300 1979 760 764
157. J.G. Kelton D. Sheridan A. Santos Heparin-induced Laboratory studies Blood 72 1988 925 930
158. J.G. Kelton J.W. Smith T.E. Warkentin Immunoglobulin G from patients with heparin-induced binds to a complex of heparin and platelet factor 4 Blood 83 1994 3232 3239
159. S.K. Khoo D.B. Rylatt P. Parsons Serial D-dimer levels in the assessment of tumor mass and clinical outcome in ovarian cancer Gynecol Oncol 29 1988 188 198
160. M.S. Khoory M.E. Nesheim E.J. Bowie K.G. Mann Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder J Clin Invest 65 1980 666 674
161. L. Kiers L.E. Grigg J.F. Cade Use of Org 10,172 in the treatment of heparin-induced thrombocytopenia and thrombosis [letter] Aust N Z J Med 16 1986 719
162. J.J. Kirshner K.W. Zamkoff A.J. Gottlieb Idiopathic thrombocytopenic purpura and Hodgkin's disease: Report of two cases and a review of the literature Am J Med Sci 280 1980 21 28
163. P. Kubisz P. Klener S. Cronberg Influence of mithramycin on some platelet functions in vitro Acta Haematol 63 1980 101 106
164. T. Kubota K. Andoh H. Sadakata Tissue factor released from leukemic cells Thromb Haemost 65 1991 59 63
165. H. Lackner Hemostatic abnormalities associated with dysproteinemias Semin Hematol 10 1973 125 133
166. H. Lackner V. Hunt M.B. Zucker J. Pearson Abnormal fibrin ultrastructure, and clot retraction in multiple myeloma Br J Haematol 18 1970 625 636
167. Q.A. Le A. Sotto A.J. Ciurana Spontaneous resolution of acquired factor X deficiency in amyloidosis J Intern Med 234 1993 329 330
168. J.B. Lesesne N. Rothschild B. Erickson hemolytic-uremic syndrome: Analysis of 85 cases from a national registry [see comments] J Clin Oncol 7 1989 781 789
169. M. Levine J. Hirsh The diagnosis and treatment of thrombosis in the cancer patient Semin Oncol 17 1990 160 171
170. M.N. Levine M. Gent J. Hirsh The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer N Engl J Med 318 1988 404 407
171. H. Liebman M. Chinowsky J. Valdin Increased fibrinolysis and amyloidosis Arch Intern Med 143 1983 678 682
172. H.A. Liebman M.K. Carfagno I.C. Weitz Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase Am J Clin Pathol 98 1992 534 541
173. A.K. Lindahl P.M. Sandset U. Abildgaard Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarction Haemostasis 20 1990 253 262
174. A.K. Lindahl P.M. Sandset U. Abildgaard High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer Acta Chir Scand 155 1989 389 393
175. P.G. Liu J.B. Jacobs Reede Trousseau's syndrome in the head and neck Am J Otolaryngol 6 1985 405 408
176. L.A. Lockman A. Mastri J.R. Priest M. Nesbit Dural venous sinus thrombosis in acute lymphoblastic leukemia Pediatrics 66 1980 943 947
177. J.J. Lokich B. Becker Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy Cancer 52 1983 1586 1589
178. J.J. Lokich T.E. Zipoli C. Moore and doxorubicin/ cyclophosphamide combination chemotherapy by continuous infusion Cancer 58 1986 1020 1023
179. F.M. Lopez B.C. Lopez R. Martin Abnormal structure of von Willebrand factor in myeloproliferative syndrome is associated to either thrombotic or bleeding diathesis Thromb Haemost 58 1987 753 757
180. G. Luzzatto A.I. Schafer The prethrombotic state in cancer Semin Oncol 17 1990 147 159
181. B.G. Macik D.A. Gabriel G. White The use of high-dose intravenous gammaglobulin in acquired von Willebrand syndrome Arch Pathol Lab Med 112 1988 143 146
182. R.G. Makhoul C.S. Greenberg R.L. McCann Heparin-associated thrombocytopenia and thrombosis: A serious clinical problem and potential solution J Vasc Surg 4 1986 522 528
183. P.M. Mannucci R. Lombardi R. Bader Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies Blood 64 1984 614 621
184. P.M. Mannucci M. Vaglini M. Maniezzo Hemostatic alterations are unrelated to the stage of tumor in untreated malignant melanoma and breast carcinoma Eur J Cancer Clin Oncol 21 1985 681 685
185. M.J. Mant J. Hirsh J. Gauldie von Willebrand's syndrome presenting as an acquired bleeding disorder in association with a monoclonal gammopathy Blood 42 1973 429 436
186. M. Maruyama K. Yagawa S. Hayashi Presence of thrombosis-inducing activity in plasma from patients with lung cancer Am Rev Respir Dis 140 1989 778 781
187. S. Matsuda I. Aoki M. Kikuchi [A case of acquired von Willebrand's syndrome associated with IgG myeloma (author's transl)] Rinsho Ketsueki 18 1977 1007 1012
188. P. McCulloch J. Douglas G.D. Lowe In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer [see comments] Thromb Haemost 61 1989 318 321
189. R. McKenna T. Ahmad C.H. Ts'ao H. Frischer Glutathione reductase deficiency and platelet dysfunction induced by sourea J Lab Clin Med 102 1983 102 115
190. R.A. McPherson J.W. Onstad R.J. Ugoretz P.L. Wolf Coagulopathy in amyloidosis: Combined deficiency of factors IX and X Am J Hematol 3 1977 225 235
191. B.F. Mertens L.F. Greene E.J. Bowie Fibrinolytic split products (FSP) and ethanol gelation test in preoperative evaluation of patients with prostatic disease Mayo Clin Proc 49 1974 642 646
192. K. Meyer E.C. Williams Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis Am J Med 79 1985 394 396
193. D.P. Mikhailidis M.A. Barradas A.M. Mikhailidis Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function Br J Clin Pharmacol 17 1984 43 48
194. M.L. Miller Heparin-induced Cleve Clin J Med 56 1989 483 490
195. S.P. Miller A.J. Sanchez T. Stefanski L. Zuckerman Coagulation disorders in cancer. I. Clinical and laboratory studies Cancer 20 1967 1452 1465
196. K.W. Min F. Gyorkey Sato Mucin-producing adenocarcinomas and nonbacterial thrombotic endocarditis: Pathogenetic role of tumor mucin Cancer 45 1980 2374 2382
197. M.C. Mitchell J.K. Boitnott S. Kaufman Budd-Chiari syndrome: Etiology, diagnosis and management Medicine (Baltimore) 61 1982 199 218
198. E.J. Mohler J.N. Kennedy P. Brakman Blood coagulation and fibrinolysis in multiple myeloma Am J Med Sci 253 1967 325 332
199. H. Mohri T. Noguchi F. Kodama Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor Am J Clin Pathol 87 1987 663 668
200. H. Mohri T. Ohkubo Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera Acta Haematol 78 1987 258 264
201. 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias Blood 60 1982 381 388
202. D. Morgan R.L. Edwards F.R. Rickles Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients Haemostasis 18 1988 55 65
203. T.J. Myers F.R. Rickles C. Barb M. Cronlund Fibrinopeptide A in acute leukemia: Relationship of activation of blood coagulation to disease activity Blood 57 1981 518 525
204. S. Nand S.G. Fisher R. Salgia R.I. Fisher Hemostatic abnormalities in untreated cancer: Incidence and correlation with thrombotic and hemorrhagic J Clin Oncol 5 1987 1998 2003
205. E.A. Natelson L.F. Brown M.W. Bradshaw Influence of cephalosporin antibiotics on blood coagulation and platelet function Antimicrob Agents Chemother 9 1976 91 93
206. P.P. Nawroth D.M. Stern Modulation of endothelial cell hemostatic properties by tumor necrosis factor J Exp Med 163 1986 740 745
207. P.B. Neame J.G. Kelton I.R. Walker Thrombocytopenia in septicemia: The role of disseminated intravascular coagulation Blood 56 1980 88 92
208. J.C. Nelson R.G. Lerner R. Goldstein N.A. Cagin Heparin-induced Arch Intern Med 138 1978 548 552
209. K. Nevasaari M. Heikkinen P.J. Taskinen Tamoxifen and thrombosis [letter] Lancet 2 1978 946 947
210. G.L. Nicolson S.E. Custead Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular integrity Cancer Res 45 1985 331 336
211. M.L. Nierodzik A. Plotkin F. Kajumo S. Karpatkin Thrombin stimulated tumor-platelet adhesion in vitro and metastasis in vivo J Clin Invest 87 1991 229 236
212. J.E. Nilehn I.M. Nilsson Coagulation studies in different types of myeloma Acta Med Scand 445 suppl 1966 194 199
213. M. Noguchi T. Sakai W. Kisiel Identification and partial purification of a novel tumor-derived protein that induces tissue factor on cultured human endothelial cells Biochem Biophys Res Commun 160 1989 222 227
214. H.L. Nossel I. Yudelman R.E. Canfield Measurement of fibrinopeptide A in human blood J Clin Invest 54 1974 43 53
215. M.J. O'Kane G.B. Wisdom Z.R. Desai G.P. Archbold Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin J Clin Pathol 47 1994 266 268
216. K. Okajima S. Koga H. Okabe Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia Acta Haematol 81 1989 15 18
217. F. Ondrias I. Slugen A. Valach Malignant tumors and embolizing paraneoplastic endocarditis Neoplasma 32 1985 135 140
218. L. Oppenheimer W.M. Hryniuk A.J. Bishop in severe bacterial infections J Surg Res 20 1976 211 214
219. F.W. Orr I.Y. Adamson Young Promotion of pulmonary metastasis in mice by bleomycin-induced endothelial injury Cancer Res 46 1986 891 897
220. R.N. Palmer M.E. Rick P.D. Rick Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder N Engl J Med 310 1984 1696 1969
221. S. Panzer E. Thaler An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myeloma Haemostasis 23 1993 69 76
222. E. Pearlstein C. Ambrogio G. Gasic S. Karpatkin Inhibition of the activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)ami de Cancer Res 41 1981 4535 4539
223. R. Penny P.A. Castaldi H.M. Whitsed Inflammation and haemostasis in Br J Haematol 20 1971 35 44
224. H.A. Perkins M.R. MacKenzie H.H. Fudenberg Hemostatic defects in dysproteinemias Blood 35 1970 695 707
225. F.W. Peuscher F.J. Cleton L. Armstrong Significance of plasma fibrinopeptide A (fpA) in patients with malignancy J Lab Clin Med 96 1980 5 14
226. B.K. Phelan thrombosis without thrombocytopenia Ann Intern Med 99 1983 637 638
227. L.J. Pillgram F. Wisloff J.J. Jorgensen Effect of high-dose ampicillin and cloxacillin on bleeding time and bleeding in open-heart surgery Scand J Thorac Cardiovasc Surg 19 1985 45 48
228. G.F. Pineo M.C. Brain A.S. Gallus Tumors, mucus production, and hypercoagulability Ann N Y Acad Sci 230 1974 262 270
229. E.M. Pogliani R. Fantasia D.G. Lambertenghi E. Cofrancesco Daunorubicin and platelet function Thromb Haemost 45 1981 38 42
230. J.R. Priest N.K. Ramsay R.E. Latchaw Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia Cancer 46 1980 1548 1554
231. C.H. Pui C.W. Jackson C.M. Chesney C.F. Abildgaard Involvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincris tine therapy for leukemia Am J Hematol 25 1987 291 298
232. A.K. Rao G.C. White L. Sherman Low incidence of thrombocytopenia with porcine mucosal heparin. A prospective multicenter study Arch Intern Med 149 1989 1285 1288
233. H. Rasche M. Dietrich Hemostatic abnormalities associated with malignant diseases Eur J Cancer 13 1977 1053 1064
234. O.D. Ratnoff Hemostatic emergencies in malignancy Semin Oncol 16 1989 561 571
235. J.B. Ray W.F. Brereton F.R. Nullet Intravenous immune globulin for the treatment of presumed quinidine-induced thrombocytopenia (authoir trans.) Drug Intelligence and Clinical Pharmacy 24 1990 693 695
236. H.D. Reuter Low-molecular weight heparin in the therapy of heparin-induced (author trans.) Med Klin 82 1987 115 118
237. G.R. Rhodes R.H. Dixon D. Silver Heparin induced thrombocytopenia: Eight cases with thrombotic-hemorrhagic complications Ann Surg 186 1977 752 758
238. F.R. Rickles R.L. Edwards Activation of blood coagulation in cancer: Trousseau's syndrome revisited Blood 62 1983 14 31
239. F.R. Rickles R.L. Edwards C. Barb M. Cronlund Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth Cancer 51 1983 301 307
240. F.R. Rickles W.W. Hancock R.L. Edwards L.R. Zacharski Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment Semin Thromb Hemost 14 1988 88 94
241. F.R. Rickles M. Levine R.L. Edwards Hemostatic alterations in cancer patients Cancer Metastasis Rev 11 1992 237 248
242. R.L. Ridolfi W.R. Bell Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature Medicine (Baltimore) 60 1981 413 428
243. E. Rocha J.A. Paramo F.J. Fernandez Clotting activation and impairment of fibrinolysis in malignancy Thromb Res 54 1989 699 707
244. G.A. Rock K.H. Shumak N.A. Buskard Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group [see comments] N Engl J Med 325 1991 393 397
245. F. Rodeghiero G. Avvisati G. Castaman Early deaths and antihemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients [see comments] Blood 75 1990 2112 2127
246. F. Rodeghiero G. Castaman The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia Leukemia 8 suppl 2 1994 S20 S26
247. F. Rodeghiero G. Castaman E. Dini Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: Evidence for activation of blood coagulation Thromb Res 57 1990 31 38
248. F. Rodeghiero P.A. Mannucci S. Vigano Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia Blood 63 1984 965 969
249. O. Roeise S. Sivertsen T.E. Ruud Studies on components of the contact phase system in patients with advanced gastrointestinal cancer Cancer 65 1990 1355 1359
250. J. Rogers A.J. Murgo J.A. Fontana P.C. Raich Chemotherapy for breast cancer decreases plasma protein C and protein S J Clin Oncol 6 1988 276 281
251. R.F. Rohner J.T. Prior J.H. Sipple Mucinous malignancies, venous thrombosis and terminal endocarditis with emboli. A syndrome Cancer 19 1966 1805 1812
252. E.D. Rosenstein S.H. Itzkowitz A.S. Penziner Resolution of factor X deficiency in primary amyloidosis following splenectomy Arch Intern Med 143 1983 597 599
253. R.N. Rubin M.S. Kies J.J. Posch Measurements of antithrombin III in solid tumor patients with and without hepatic metastases Thromb Res 18 1980 353 360
254. D. Ruggero M. Baccarani A. Guarini Acute promyelocytic leukemia: Results of therapy and analysis of 13 cases Acta Haematol 58 1977 108 119
255. G.J. Sack J. Levin W.R. Bell Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic, and therapeutic features Medicine (Baltimore) 56 1977 1 37
256. T. Saphner D.C. Tormey R. Gray Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer J Clin Oncol 9 1991 286 294
257. F.R. Sattler M.R. Weitekamp J.O. Ballard Potential for bleeding with the new betalactam antibiotics Ann Intern Med 105 1986 924 931
258. R. Sawaya P.L. Kornblith Brain tumors and complications [editorial] Surg Neurol 28 1987
259. B.S. Schwartz E.C. Williams M.G. Conlan D.F. Mosher Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency Ann Intern Med 105 1986 873 877
260. I. Schwarzinger K.M. Stain P. Bettelheim Recurrent, isolated factor X deficiency in myeloma: Repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosis Thromb Haemost 68 1992 648 651
261. J.P. Scott R.R. Montgomery D.G. Tubergen T. Hays Acquired von Willebrand's disease in association with Wilms' tumor: Regression following treatment Blood 58 1981 665 669
262. D.R. Senger L. Van de Water L.F. Brown Vascular permeability factor (VPF, VEGF) in tumor biology Cancer Metastasis Rev 12 1993 303 324
263. B. Shapiro J. Jude I. Goudemand Lupus anticoagulant: A clinical and laboratory study of 100 cases Clin Lab Haematol 10 1988 41 51
264. S.J. Shattil J.S. Bennett M. McDonough J. Turnbull Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface J Clin Invest 65 1980 329 337
265. L. Sheiman A.R. Spielvogel H.I. Horowitz Thrombocytopenia caused by cephalothin sodium. Occurrence in a individual JAMA 203 1968 601 603
266. D. Sheridan C. Carter J.G. Kelton A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27 30
267. S. Sherlock Extrahepatic portal venous hypertension in adults Clin Gastroenterol 14 1985 1 19
268. N. Sitbon M.H. Horellou J. Conard [Acquired von Willebrand factor deficiency associated with monoclonal IgG kappa gammapathy. Presence of an inhibitor of ristocetin co-factor (author's transl)] Nouv Presse Med 10 1981 2171 2174
269. M.H. Sketch M. Cale S.M. Mohiuddin R.W. Booth Use of percutaneously inserted venous catheters in coronary care units Chest 62 1972 684 689
270. S.J. Slichter L.A. Harker Hemostasis in malignancy Ann N Y Acad Sci 230 1974 252 261
271. E.M. Sloand D.M. Kenney F.C. Chao Platelet antithrombin defect in malignancy: Platelet protein alterations Blood 69 1987 479 485
272. J. Solomon T. Bofenkamp J.L. Fahey Platelet prophylaxis in acute non-lymphoblastic leukaemia [letter] Lancet 1 1978 267
273. B.C. Soong S.P. Miller Coagulation disorders in cancer. 3. Fibrinolysis and inhibitors Cancer 25 1970 867 874
274. P. Spath G. Garratty Petz Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin J Immunol 107 1971 860 869
275. J.A. Spero J.H. Lewis U. Hasiba L.D. Ellis Treatment of amyloidosis associated factor X deficiency Thromb Haemost 35 1976 377 381
276. R.B. Stead A.I. Schafer R.D. Rosenberg Heterogeneity of heparin lots associated with and thromboembolism Am J Med 77 1984 185 188
277. R.H. Steingart Coagulation disorders associated with neoplastic disease Recent Results Cancer Res 108 1988 37 43
278. L. Sterrenberg H.L. Haak E.J. Brommer W. Nieuwenhuizen Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia Haemostasis 15 1985 126 133
279. N.C. Sun W.M. McAfee G.J. Hum J.M. Weiner Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies Am J Clin Pathol 71 1979 10 16
280. J.D. Sweeney K.M. Killion C.F. Pruet M.B. Spaulding von Willebrand factor in head and neck cancer Cancer 66 1990 2387 2389
281. H. Takahashi R. Nagayama Y. Tanabe DDAVP in acquired von Willebrand syndrome associated with multiple myeloma Am J Hematol 22 1986 421 429
282. H. Takahashi W. Tatewaki K. Wada Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders [see comments] Am J Hematol 33 1990 90 95
283. M.S. Tallman H.C. Kwaan Reassessing the hemostatic disorder associated with acute promyelocytic leukemia [see comments] Blood 79 1992 543 553
284. A. Tefferi W.L. Nichols E.J. Bowie Circulating heparin-like anticoagulants: Report of five consecutive cases and a review Am J Med 88 1990 184 188
285. P. Thiagarajan S.S. Shapiro M.L. De Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant J Clin Invest 66 1980 397 405
286. A. Trousseau Phlegmasia alba dolens. Clinique Medicale de l'Hotel-Dieu de Paris 3 1865 The New Sydenham Society London 94
287. K. Troy D. Essex J. Rand Protein C and S levels in acute leukemia Am J Hematol 37 1991 159 162
288. T. Uchiyama M. Matsumoto N. Kobayaashi Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy Thromb Res 59 1990 955 965
289. D. Valla N. Casadevall M.G. Huisse Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders Gastroenterology 94 1988 1063 1069
290. M.B. Van der Weyden H. Hunt K. McGrath Delayed-onset heparin-induced thrombocytopenia. A potentially malignant syndrome Med J Aust 2 1983 132 135
291. F. Velasco A. Torres P. Andres Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia Thromb Haemost 52 1984 81 84
292. E.M. Vigliano H.I. Horowitz Bleeding syndrome in a patient with IgA myeloma: Interaction of protein and connective tissue Blood 29 1967 823 836
293. J.F. Vitoux J.F. Mathieu M. Roncato Heparin-associated thrombocytopenia treatment with low molecular weight heparin Thromb Haemost 55 1986 37 39
294. C.C. Waddell P.L. Cimo Idiopathic thrombocytopenic purpura occurring in Hodgkin disease after splenectomy: Report of two cases and review of the literature Am J Hematol 7 1979 381 387
295. T. Wajima Fibrinolytic profiles in patients with small cell carcinoma of the lung Semin Thromb Hemost 17 1991 280 285
296. J.G. Wall R.B. Weiss L. Norton Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: A Cancer and Leukemia Group B Study Am J Med 87 1989 501 504
297. T.E. Warkentin J.G. Kelton Heparin-induced Prog Hemost Thromb 10 1991 1 34
298. T.E. Warkentin M.N. Levine J. Hirsh in patients treated with heparin or unfractionated heparin [see comments] N Engl J Med 332 1995 1330 1335
299. J.L. Wautier J. Fusciardi A. Warnet [Acquired Von Willebrand disease with chronic lymphocytic leukaemia and angiodysplasia (author's transl)] Nouv Presse Med 6 1977 3733 3734
300. J.L. Wautier T.S. Levy J.P. Caen Acquired von Willebrand's syndrome and thrombopathy in a patient with chronic lymphocytic leukaemia Scand J Haematol 16 1976 128 134
301. R.B. Weiss D.C. Tormey J.F. Holland V.E. Weinberg Venous thrombosis during multimodal treatment of primary breast carcinoma Cancer Treat Rep 65 1981 677 679
302. M.R. Weitekamp R.C. Aber Prolonged bleeding times and bleeding diathesis associated with moxalactam JAMA 249 1983 69 71
303. P.W. White J.R. Sadd R.E. Nensel Thrombotic complications of heparin therapy: Including six cases of heparin-induced skin necrosis Ann Surg 190 1979 595 608
304. J.T. Wilde S. Kitchen S. Kinsey Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states Br J Haematol 71 1989 65 70
305. E.M. Woerner R.L. Rowe Trousseau's syndrome Am Fam Physician 38 1988 195 201
306. L.R. Zacharski T.E. Moritz L.A. Baczek Effect of mopidamol on survival in carcinoma of the lung and colon: Final report of Veterans Administration Cooperative Study No. 188 J Natl Cancer Inst 80 1988 90 97
307. K.D. Zeitler P.M. Blatt Amyloidosis and factor X deficiency South Med J 75 1982 306 308
308. O. Zettervall I.M. Nilsson Acquired von Willebrand's disease caused by a monoclonal antibody Acta Medica Scandinavica 204 1978 521 528